Brown Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,829,886
Closed -$13.8M 115
2019
Q4
$13.8M Buy
1,829,886
+133,596
+8% +$1.01M 0.13% 44
2019
Q3
$7.06M Buy
1,696,290
+171,862
+11% +$715K 0.07% 46
2019
Q2
$4.41M Buy
1,524,428
+124,421
+9% +$360K 0.04% 49
2019
Q1
$2.02M Buy
1,400,007
+304,130
+28% +$438K 0.02% 63
2018
Q4
$2.83M Buy
1,095,877
+85,700
+8% +$221K 0.03% 55
2018
Q3
$4.44M Buy
1,010,177
+51,315
+5% +$225K 0.04% 51
2018
Q2
$5.88M Buy
958,862
+46,164
+5% +$283K 0.06% 49
2018
Q1
$6.65M Buy
912,698
+27,652
+3% +$202K 0.08% 50
2017
Q4
$7.26M Buy
885,046
+8,091
+0.9% +$66.3K 0.09% 48
2017
Q3
$9.21M Buy
876,955
+5,488
+0.6% +$57.6K 0.11% 47
2017
Q2
$9.61M Sell
871,467
-92,514
-10% -$1.02M 0.12% 47
2017
Q1
$9.33M Sell
963,981
-5,681
-0.6% -$55K 0.12% 47
2016
Q4
$10.1M Buy
969,662
+43,103
+5% +$448K 0.15% 47
2016
Q3
$11.5M Buy
926,559
+136,353
+17% +$1.69M 0.17% 47
2016
Q2
$8.49M Buy
790,206
+211,392
+37% +$2.27M 0.13% 53
2016
Q1
$6.39M Buy
578,814
+357
+0.1% +$3.94K 0.11% 63
2015
Q4
$7.06M Buy
578,457
+24,398
+4% +$298K 0.11% 67
2015
Q3
$9.04M Sell
554,059
-7,967
-1% -$130K 0.15% 61
2015
Q2
$11.9M Buy
562,026
+13,581
+2% +$288K 0.2% 59
2015
Q1
$9.86M Hold
548,445
0.16% 65
2014
Q4
$9.4M Sell
548,445
-13,133
-2% -$225K 0.16% 66
2014
Q3
$8.04M Buy
561,578
+17,835
+3% +$255K 0.14% 76
2014
Q2
$8.16M Buy
543,743
+51,458
+10% +$772K 0.14% 77
2014
Q1
$6.6M Buy
492,285
+914
+0.2% +$12.2K 0.11% 80
2013
Q4
$3.96M Sell
491,371
-3,531
-0.7% -$28.4K 0.06% 88
2013
Q3
$3.25M Sell
494,902
-21,393
-4% -$140K 0.06% 90
2013
Q2
$3.18M Buy
+516,295
New +$3.18M 0.07% 90